Better treatment for common childhood brain cancer

June 26, 2012
Pediatric Cancer Genome Project researchers identified potential drug targets for medulloblastoma. Credit: St. Jude Children’s Research Hospital

Children diagnosed with the most common paediatric malignant brain cancer, medulloblastoma, will benefit from more targeted treatment following the identification of genetic mutations in the cancer.

The international research findings published in Nature may lead to the development of and better outcomes for patients, says Richard Cohn, Conjoint Associate Professor at the University of New South Wales.

A specialist at the Centre for Children’s Cancer and Blood Disorders, Associate Professor Cohn contributed to the research led by a team at St. Jude Comprehensive Cancer Center in the United States.

“The discovery of tumour-specific gene alterations linked to subtypes of provides important insights into the development of the cancer and highlights targets for new treatment approaches,” he said.

The findings were a direct result of collaboration between six children’s oncology centres internationally, which pooled patient specimens and information.

“Now that we know about these mutations, the hope is we’ll be able to develop new drugs, or utilise existing drugs not currently used to treat this disease, to specifically attack the molecular abnormality,” Associate Professor Cohn said.

“Ideally this will lead to better outcomes for patients and better cure rates and the ability to achieve that with fewer side effects.”

Explore further: Researchers find simple reason why some children die despite aggressive modern therapy for brain cancer

Related Stories

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.